SEC Form 4 · accession 0001140361-17-045556
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Zsolt Harsanyi
Director
Period of report
Dec 7, 2017
Accepted (ET)
Dec 11, 2017 · 8:25 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 7, 2017 | S | 7,000 | $42.47 | D | 37,077 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of vested restricted stock units granted under the Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended and restated.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.35 to $42.59, inclusive.